" class="no-js "lang="en-US"> GE Healthcare - Medtech Alert
Friday, August 15, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
GE Healthcare | Pharmtech Focus

GE Healthcare

About GE Healthcare

GE Healthcare

Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence.

As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

We embrace a culture of respect, transparency, integrity and diversity.

Related Story

Cardiovascular

 Centerline Biomedical Raises $33 Million in Series B Financing | Pharmtech Focus

Centerline Biomedical Raises $33 Million in Series B Financing

June 28 2022

Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series […]

COVID-19

 Medtronic and GE Healthcare Announce a Collaboration to Meet Growing Need for Outpatient Care | Pharmtech Focus

Medtronic and GE Healthcare Announce a Collaboration to Meet Growing Need for Outpatient Care

April 29 2022

Providing excellent care inside and outside of the traditional hospital is the new normal for […]

Manufacturing

 GE Healthcare Unveils Next Gen Portable X-Ray System to Help Address Technologist Stress and Strain and Improve Efficiency | Pharmtech Focus

GE Healthcare Unveils Next Gen Portable X-Ray System to Help Address Technologist Stress and Strain and Improve Efficiency

September 2 2021

GE Healthcare introduced the AMX Navigate, a new portable, digital X-ray system designed with a […]